Cargando…
Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease
In cystic fibrosis (CF), the accumulation of viscous lung secretions rich in DNA and actin is a major cause of chronic inflammation and recurrent infections leading to airway obstruction. Mucolytic therapy based on recombinant human DNase1 reduces CF mucus viscosity and promotes airway clearance. Ho...
Autores principales: | Delfino, Danila, Mori, Giulia, Rivetti, Claudio, Grigoletto, Antonella, Bizzotto, Gloria, Cavozzi, Cristian, Malatesta, Marco, Cavazzini, Davide, Pasut, Gianfranco, Percudani, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002113/ https://www.ncbi.nlm.nih.gov/pubmed/33802146 http://dx.doi.org/10.3390/biom11030410 |
Ejemplares similares
-
Origin and significance of the human DNase repertoire
por: Mori, Giulia, et al.
Publicado: (2022) -
Identification of hidden associations among eukaryotic genes through statistical analysis of coevolutionary transitions
por: Dembech, Elena, et al.
Publicado: (2023) -
Functional characterization and transcriptional repression by Lacticaseibacillus paracasei DinJ-YafQ
por: Bonini, Aleksandra Anna, et al.
Publicado: (2022) -
cfDNA and DNases: New Biomarkers of Sepsis in Preterm Neonates—A Pilot Study
por: Lenz, Moritz, et al.
Publicado: (2022) -
Improving the
Therapeutic Potential of G-CSF
through Compact Circular PEGylation Based on Orthogonal Conjugations
por: Grigoletto, Antonella, et al.
Publicado: (2023)